BioCentury - The latest twist in the overall survival debate
A real-world 1:1 propensity-matched study revealed unmarried status was independently associated with worse survival for patients with renal clear cell carcinoma
Six RNA binding proteins (RBPs) related prognostic model predicts overall survival for clear cell renal cell carcinoma and is associated with immune infiltration | Biomolecules and Biomedicine
Kaplan–Meier curves depicting overall survival (OS; a, b) and... | Download Scientific Diagram
Oncotarget: Identification intermediate-risk | EurekAlert!
CLEAR Study: First-Line Lenvatinib Plus Pembrolizumab Maintains Advantage Over Sunitinib in Advanced RCC at Long-Term Follow-up
Stream Final Overall Survival Results of the CLEAR Study in Renal Cell Carcinoma With Thomas Hutson, MD by Oncology Data Advisor® | Listen online for free on SoundCloud
Non-Small Cell Lung Cancer
Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma - Figure f3 | Aging
ASCO 2022: Progression-Free Survival After Second Line of Therapy (PFS-2) for Metastatic Clear Cell RCC in Patients Treated With First-Line Immunotherapy Combinations
A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study - The Lancet Digital Health
Outcomes of Patients With Advanced Renal Cell Carcinoma With Non-Clear Cell Histology Treated With Systemic Therapy - Clinical Genitourinary Cancer
Overall survival vs immunohistochemistry. The Kaplan Meier graph... | Download Scientific Diagram
Oncology Data Advisor - Final Overall Survival Results of the CLEAR Study in Renal Cell Carcinoma
MP47-11 DIFFERENTIAL ASSOCIATION OF BODY MASS INDEX ON SURVIVAL OUTCOMES IN RENAL CELL CARCINOMA: IMPACT OF TUMOR HISTOLOGY | Journal of Urology
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC | NEJM
IDH1 R132C mutation is detected in clear cell hepatocellular carcinoma by pyrosequencing | World Journal of Surgical Oncology | Full Text
Serum Lactate Dehydrogenase Before Nivolumab Treatment Could Be a Therapeutic Prognostic Biomarker for Patients With Metastatic Clear Cell Renal Cell Carcinoma | Anticancer Research
Decreased expression of JMJD3 predicts poor prognosis of patients with clear cell renal cell carcinoma
Prognostic Value of Serum CA9 in Patients with Metastatic Clear Cell Renal Cell Carcinoma under Targeted Therapy | Anticancer Research
A Novel Nomogram Predicting the Overall Survival of Patients with Metastatic Non-clear Cell Renal Cell Carcinoma: A Large Population-Based Investigation | SpringerLink
Cancers | Free Full-Text | Evaluation of Survival, Recurrence Patterns and Adjuvant Therapy in Surgically Staged High-Grade Endometrial Cancer with Retroperitoneal Metastases
Kaplan–Meier estimates the (A) cancer-specific and (B) overall survival... | Download Scientific Diagram
A Molecular Model for Predicting Overall Survival in Patients with Metastatic Clear Cell Renal Carcinoma: Results from CALGB 90206 (Alliance) - eBioMedicine
